Chemotherapy for patients with hormone-refractory prostate cancer
- PMID: 15520057
- DOI: 10.1093/annonc/mdh445
Chemotherapy for patients with hormone-refractory prostate cancer
Comment on
-
Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer.Ann Oncol. 2004 Nov;15(11):1613-21. doi: 10.1093/annonc/mdh429. Ann Oncol. 2004. PMID: 15520061 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
